Position in INVA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$5,343,575
+$955,491 QoQ
Shares Held
229,338
+4.5% QoQ
Ownership
0.311%
of shares outstanding
% of Portfolio
0.59%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2023
11 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in INVA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Uniplan Investment Counsel, Inc. holds $19,321,657 across 4 Biotechnology names. INVA ranks #2 (27.7% of the industry book) .
All Filings in INVA
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,343,575 | 229,338 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $4,388,084 | 219,514 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $3,494,327 | 191,470 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $4,476,795 | 222,837 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $4,414,781 | 243,507 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $4,198,942 | 242,014 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $4,728,130 | 244,854 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $4,085,108 | 249,092 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $2,845,429 | 186,708 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $2,971,361 | 185,247 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,492,858 | 191,906 | Shares | Sole | 2023-11-14 | |
| No filing history on record for this holder in this stock. | ||||||